Story · Medicine & Biotech
Effects of semaglutide on cardiac structure and function in heart failure with preserved ejection fraction and obesity: a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial
1 outlet · first reported by Nature Medicine 4d ago · latest 4d ago
Coverage, in order
-
4d agoEffects of semaglutide on cardiac structure and function in heart failure with preserved ejection fraction and obesity: a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial
Nature Medicine, Published online: 08 November 2026; doi:10.1038/s41591-026-04787-8 As presented at the 2026 AHA Scientific Sessions, a cardiac magnetic resonance substudy of the CAMEO-SEMA trial showed that semaglutide significantly improved cardiac structure and function, including left atrial…
-
4d agoHemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial
Nature Medicine, Published online: 08 November 2026; doi:10.1038/s41591-026-04762-3 As presented at the 2026 American Heart Association Scientific Sessions, in a placebo-controlled randomized clinical trial, semaglutide significantly improved pulmonary artery wedge pressure and other hemodynamic…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.